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Abstract
Amyloid-beta (Aβ) plaques and tau neurofibrillary tangles are pathological hallmarks
of Alzheimer's disease (AD); their contribution to neurodegeneration and clinical
manifestations are critical in understanding preclinical AD. At present, the mecha-
nisms related to Aβ and tau pathogenesis leading to cognitive decline in older adults
remain largely unknown. Here, we examined graph theory-based positron emission
tomography (PET) analytical approaches, within and between tau and Aβ PET modali-
ties, and tested the effects on cognitive changes in cognitively normal older adults
(CN). Particularly, we focused on the network interdigitations of Aβ and tau deposits,
along with cognitive test scores in CN at both baseline and 2-year follow-up (FU).
We found highly significant Aβ-tau network integrations in AD vulnerable areas, as
well as significant associations between those Aβ-tau interdigitations and general
cognitive impairment in CN at baseline and FU. Our findings suggest a distinctive
contribution of interlinking network relationships between Aβ and tau deposits in
heteromodal areas of the human brain. They support a network-based interaction
between Aβ and tau accumulations as a key factor for cognitive deterioration in CN
prior to dementia.
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1 | INTRODUCTION
Alzheimer's disease (AD) is the most common type of dementia char-
acterized by progressive memory loss and the loss of independence in
daily activities. Aggregation of amyloid-beta (Aβ) peptides and accu-
mulation of aggregated forms of tau proteins are pathological hall-
marks of AD, appearing in initial stages of AD prior to onset of
symptoms (Fleisher et al., 2015; Jack Jr et al., 2010; Jansen
et al., 2015). Two pathological hallmarks, Aβ plaques and the neurofi-
brillary tangles, are considered sensitive markers for AD, and their
contribution to neurodegeneration and cognitive decline is presumed
to be a key to understand preclinical AD (Ballard et al., 2011; Johnson
et al., 2013; Pike et al., 2007). However, at present, it remains largely
unknown how Aβ and tau accumulation spatially intersect in brain cir-
cuits and whether these factors may explain the emergence of cogni-
tive decline in older adults.
Increased Aβ plaques and tau neurofibrillary tangles are com-
monly found in the neocortex of AD patients in postmortem autopsies
(Braak & Braak, 1991a, 1991b, 1995) as well as in positron emission
tomography (PET) imaging studies (Barthel et al., 2011; Chien
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et al., 2013; Clark et al., 2011; Clark et al., 2012; Johnson et al., 2016;
Klunk et al., 2004; Marquié et al., 2015; Pike et al., 2007; Van-
denberghe et al., 2010; Wong et al., 2010). The coexistence of both
pathological hallmarks is associated with synaptic dysfunction and
neuronal loss that mediate memory and cognition (Iqbal & Grundke-
Iqbal, 2002; Selkoe, 2002; Sperling et al., 2019). Several studies have
shown a strong association between Aβ and greater tau accumula-
tions at the cellular and molecular levels (Bennett et al., 2017; Götz,
Chen, Van Dorpe, & Nitsch, 2001; He et al., 2018; Hurtado
et al., 2010; Lewis et al., 2001; Williamson, Usardi, Hanger, &
Anderton, 2008). The spatial association between Aβ and tau accumu-
lations is somewhat inconsistent or minimally overlapping in specific
regions of the brain in older adults prior to dementia (Schöll
et al., 2016; Whitwell et al., 2018). Aβ plaques first arise in the neo-
cortex and spread to deep subcortical regions, while tau neurofibril-
lary tangles occur in entorhinal and limbic areas first, then spread to
the neocortical areas (Arnold, Hyman, Flory, Damasio, & Van
Hoesen, 1991; Braak & Braak, 1991b, 1995). Thus, the lack of spatial
consistency between Aβ and tau accumulations has resulted from the
distinctive spreading patterns of Aβ pathology and tau pathology in
AD progression (Arnold et al., 1991; Braak & Braak, 1991b, 1995).
Although there is not a perfect alignment of spatial distributions, a
potential contribution of global Aβ accumulation to increasing accu-
mulation of tau was suggested by several imaging studies (Jacobs
et al., 2018; Pontecorvo et al., 2017; Quiroz et al., 2018; Wang
et al., 2016), particularly if distributed network information is taken
into consideration. In fact, it is now known that regions of Aβ and tau
accumulation show network bonds, even without spatial overlapping
between them (Brier et al., 2016;Iaccarino et al., 2018; Sepulcre
et al., 2016). Therefore, understanding the spatial and network inter-
actions between Aβ and tau accumulations in cognitively healthy par-
ticipants may elucidate the underlying role of both pathologies in the
development of cognitive decline.
Given the increasing evidence of the transcellular propagation of
AD pathogenesis along neuronal circuits as well as in functionally
linked distributed regions (Braak & Del Tredici, 2011; Clavaguera
et al., 2009; De Calignon et al., 2012; Guo & Lee, 2014; Iba
et al., 2013; Stöhr et al., 2012; Thal, Rub, Orantes, & Braak, 2002;
Walker & Jucker, 2011), graph theory-based network approaches
have been applied to understand how Aβ and tau propagate in the
in vivo human brain (Kim et al., 2019; Sepulcre et al., 2016; Sepulcre
et al., 2018). The network-based spatial spreading patterns of Aβ and
tau accumulations have shown distinctive pathways, such as tau prop-
agation from medial/inferior temporal lobe to orbitofrontal cortex,
and Aβ propagation from posterior cingulate cortex (PCC) to lateral
parietal lobe, in older adults (Sepulcre et al., 2016), mild AD (Iaccarino
et al., 2018), and AD spectrum patients (Kim et al., 2019). However,
some hubs of both Aβ and tau pathology networks overlapped in
regions which are partly associated with AD vulnerability (Iaccarino
et al., 2018; Kim et al., 2019; Sepulcre et al., 2016; Sepulcre
et al., 2018). Additionally, local tau accumulation was significantly
associated with distributed Aβ accumulation, which suggested a
potential network dependency between Aβ and tau accumulations in
older adults or mild AD (Iaccarino et al., 2018; Sepulcre et al., 2016).
Previously, a strong association between the spatial distribution
of tau accumulation and cognitive impairment was observed, primarily
in the medial temporal lobe (MTL), in older adults and AD (Ghoshal
et al., 2002; Mitchell et al., 2002; Nelson et al., 2012; Quiroz
et al., 2018; Rolstad et al., 2013; van Rossum et al., 2012). Although
tau is more closely associated with cognitive impairment than Aβ
(Ghoshal et al., 2002; Mitchell et al., 2002; Nelson et al., 2012; Quiroz
et al., 2018; Rolstad et al., 2013; van Rossum et al., 2012), a significant
association between the longitudinal trajectories of Aβ and the pro-
gressive cognitive decline, particularly memory function, has been also
observed in aging or in the early stages of AD (Hanseeuw et al., 2019;
Landau et al., 2012; Resnick et al., 2010; Villemagne et al., 2013).
Other studies have suggested that neocortical Aβ accumulation
potentially contributes to the association of tau with cognitive impair-
ment in older adults (Hanseeuw et al., 2019; Jacobs et al., 2018; Schöll
et al., 2016; Sperling et al., 2019) and early stages of AD (Fagan
et al., 2007; Johnson et al., 2016). However, the mechanism of the
association between Aβ and tau pathogenesis that links to cognitive
decline in older adults prior to AD remains largely unknown.
Given that the network physical dependencies and overlapping
distributions of Aβ and tau in the neocortex -also called Aβ-tau inter-
digitations in this study- have been suggested recently (Kim
et al., 2019; Sepulcre et al., 2016; Sepulcre et al., 2018), it is critical to
examine whether Aβ accumulation and tau accumulation affect subtle
cognitive impairment independently, or combination of Aβ and tau
accumulations have synergetic effects in older adults with clinically
normal cognition prior to symptom onset. To date, little is known
about the role of the association between Aβ and tau accumulations
in longitudinal cognitive changes in aging. Therefore, investigating the
network-based PET correlation between Aβ and tau deposits, and
their association with the cognitive variability in older adults may pro-
vide insights into how preclinical AD progresses into a more patent
cognitive failure.
In this study, we explore the network-based relationships
between Aβ and tau accumulations in cognitively healthy older adults
measured by PET images. Next, we examine the association between
PET network profiles and neuropsychological (NP) test scores in order
to understand the effects of the Aβ and tau network relationships at
baseline and 2-year follow-up (FU). Our findings support the distinc-
tive contribution of Aβ-tau pathological connectivity crosstalk in the
appearance of the initial cognitive changes in putative preclinical
stages of AD in older adults.
2 | MATERIALS AND METHODS
2.1 | Participants
A total of 193 cognitively normal older adults (CN) from Alzheimer's
Disease Neuroimaging Initiative (ADNI) projects (http://www.loni.
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ucla.edu/ADNI/) who completed cognitive assessment, T1-weighted
magnetic resonance imaging (MRI), 18F-Florbetapir (FBP) PET, and
18F-AV-1451 (tau) PET at baseline visits were investigated. We
excluded nine subjects due to technical limitations of image processing,
such as a failure of coregistration between T1-MRI and PET or the fail-
ure of the partial volume correction (PVC) process in PET images. All
data used in this study was acquired from ADNI-3 project between
August 2016 and December 2019 (Weiner et al., 2017). Cognitive
assessment was performed using NP tests, such as Clinical Dementia
Rating, Mini Mental State Examination (MMSE) (Folstein, Folstein, &
McHugh, 1975), Geriatric Depression Scale, Rey Auditory Verbal Learn-
ing Test (RAVALT) (Rey, 1958), Alzheimer's Disease Assessment Scale-
Cognitive Subscale (ADAS-Cog) (Mohs et al., 1997a, 1997b), ADNI
composite score for memory (ADNI-MEM) (Crane et al., 2012), and
ADNI composite score for executive function (ADNI-EF) (Gibbons
et al., 2012). We additionally investigated the FU data in twenty CN,
who completed the cognitive assessment, T1-weighted MRI, FBP PET
and tau PET at the 2-year FU time point, for the validation analysis in
this study. Two FU data were excluded due to the failure of the PET-
preprocessing. Finally, we defined three groups of CN, with 184 CN at
baseline, 18 CN at 2-year FU, and FU-matched 18 CN at baseline, for
the longitudinal analysis. FU-matched CN at baseline was subselected
from all CN at baseline. Detailed demographic characteristics and NP
test scores of all participants are described in Table 1.
2.2 | MRI acquisition
T1-weighted MRIs were acquired using an accelerated sagittal
magnetization-prepared rapid gradient echo sequence on 3-T SIE-
MENS systems (repetition time = 2.3 ms, echo time = 2.9 ms, flip
angle = 9.0, image matrix = 256 × 256, 210 slices, voxel
size = 1.0 × 1.0 mm, slice thickness = 1.0 mm) or on 3-T Phillips Sys-
tems (repetition time = 6.5 ms, echo time = 2.9 ms, flip angle = 9.0,
image matrix = 256 × 256, 210 slices, voxel size = 1.0 × 1.0 mm, slice
thickness = 1.0 mm). Some T1-weighted MRIs were acquired using an
accelerated sagittal inversion recovery-prepared fast spoiled gradient-
echo sequence on 3-T GE systems (repetition time = 7.7 ms, echo
time = 3.1 ms, flip angle = 11.0, image matrix = 256 × 256, 196 slices,
voxel size = 1.0 × 1.0 mm, slice thickness = 1.0 mm). Detailed infor-
mation of the MRI acquisition protocol is available from ADNI website
(http://www.loni.ucla.edu/ADNI/).
2.3 | PET acquisition
FBP (Aβ) PET scan was performed for 20 min in duration by 4-by-5 min
frames and was acquired starting 50–70 min after injection of
10.0 ± 1.0 mCi F18-Florbetapir. Tau PET scan was performed for
30 min in duration by 6-by-5 min frames and was acquired starting
75–105 min after injection of 10.0 ± 1.0 mCi F18-AV-1451. Both FBP
PET and tau PET images were acquired using one of several PET scan-
ners, including GE, Siemens, or Phillips Medical Systems. The detailed
methods for FBP PET and tau PET acquisitions are described elsewhere
(Weiner et al., 2017). We used an averaged single FBP PET and the
averaged single tau PET from ADNI database, which were generated
by averaging all frames of FBP PET or tau PET image set. All PET
images were reconstructed with 1.02 × 1.02 mm pixel size and 2.0 mm
slice thickness; or 1.33 × 1.33 mm pixel size and 3.27 mm slice thick-
ness; or 2.0 × 2.0 mm pixel size and 3.27 mm slice thickness depending
on their scanner types. Detailed PET acquisition information is available
from ADNI website (http://www.loni.ucla.edu/ADNI/).
TABLE 1 Demographics and clinical characteristics
CN at baseline (n = 184) FU-matched CN at baseline (n = 18) CN at 2-year FU (n = 18)
Gender F = 106/M = 78 F = 11/M = 7 F = 11/M = 7
Age (years) 74.92 ± 9.50 77.13 ± 6.31 79.22 ± 7.22
Education (years) 16.25 ± 3.44 15.30 ± 4.32 15.30 ± 4.32
MMSE 28.80 ± 2.51 29.06 ± 1.21 28.40 ± 1.64
CDR (IQR) 0.04 (0.0–0.0) 0.11 (0.0–0.0) 0.25 (0.0–0.5)
MoCA 24.73 ± 3.41 24.72 ± 3.20 23.35 ± 3.25
GDS 0.92 ± 1.57 0.89 ± 1.49 1.35 ± 1.87
RAVALT 45.24 ± 10.63 44.00 ± 8.22 36.00 ± 14.59
ADAS-Cog 12.97 ± 5.22 13.04 ± 4.40 13.53 ± 6.35
ADNI-MEM 0.93 ± 0.56 0.83 ± 0.40 0.66 ± 0.86
ADNI-EF 1.02 ± 0.79 1.18 ± 0.80 0.92 ± 0.74
Amyloid positivity (global FBP-SUVR ≥ 1.10) 30.77% 44.44%
tau positivity (composite ROIs ≥ 1.25) 2.73% 5.56%
Abbreviations: ADAS-Cog, Alzheimer's Disease Assessment Scale-Cognitive Subscale; ADNI-EF, Alzheimer's Disease Neuroimaging Initiative composite
score for executive function; ADNI-MEM, Alzheimer's Disease Neuroimaging Initiative composite score for memory; CDR, Clinical Dementia Rating; CN,
cognitively normal older adults; FBP, 18F-Florbetapir; FU, follow-up; GDS, Geriatric Depression Scale; IQR, interquartile range; MMSE, Mini Mental State
Examination; MoCA, Montreal Cognitive Assessment; RAVALT, Rey Auditory Verbal Learning Test; SUVR, standardized uptake value ratio.
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2.4 | MRI image processing
All T1-weighted MRIs at baseline and 2-year FU were automatically
processed by FreeSurfer recon-all procedure (FreeSurfer version
6.0.0; http://surfer.nmr.mgh.harvard.edu/) to reconstruct cortical sur-
faces and to segment region-of-interests (ROI) volumes (Dale, Fischl, &
Sereno, 1999; Desikan et al., 2006; Fischl, Sereno, Tootell, &
Dale, 1999). The ROI volumes were defined by the gyral-based
Desikan–Killiany atlas through an automated FreeSurfer process,
which used the depth from one sulcus to another to parcellate the
cerebral cortex into standard neuroanatomical regions, for each indi-
vidual MRI (Desikan et al., 2006). All technical details of these proce-
dures are described in prior publications (Dale et al., 1999; Desikan
et al., 2006; Fischl et al., 2002; Fischl, van der Kouwe, et al., 2004; Fis-
chl, Salat, et al., 2004; Fischl, Liu, & Dale, 2001). The brain tissues,
including gray matter (GM), white matter (WM), and cerebrospinal
fluid, were segmented from T1-weighted MRI and volume registered
into Montreal Neurological Institute/International Consortium for
Brain Mapping (MNI/ICBM) space using watershed/surface deforma-
tion procedure (Ségonne et al., 2004). The registered MRIs automati-
cally mapped into a common surface template using a surface-based
averaging technique by considering cortical folding patterns. Then,
predefined ROIs in the standard space were inversely mapped to each
native MRI using a high-dimensional spherical morphing procedure to
segment the ROIs in each individual (Fischl et al., 2002; Fischl, Salat,
et al., 2004; Fischl, van der Kouwe, et al., 2004). In order to calculate
the standard uptake value ratio (SUVR) and to perform the PVC in
PET image processing, we used ROIs to define the reference regions
of PET images for each individual.
2.5 | PET image processing
All FBP PET and tau PET at both baseline and 2-year FU were
processed by FMRIB Software Library (FSL; http://fsl.fmrib.ox.ac.uk)
and FreeSurfer PetSurfer procedure (FreeSurfer version 6.0.0; http://
surfer.nmr.mgh.harvard.edu/fswikiPetSurfer/) to perform cor-
egistration, calculation of SUVR, and to perform PVC (Greve
et al., 2016). Each individual FBP PET or tau PET image was cor-
egistered to the corresponding native T1-weighted MRI using a rigid-
body registration with mutual information cost function. All ROIs that
segmented from individual MRI were inversely registered to each indi-
vidual FBP PET or tau PET by using an inverse transformation of each
coregistration matrix. Then, each individual FBP PET or tau PET was
scaled by a mean value in the cerebellar gray reference region to cal-
culate the SUVR (Sepulcre et al., 2018). To examine the pathological
status of our population, we additionally investigated amyloid-
positivity and tau-positivity in CN at baseline. The amyloid-positivity
was defined by considering the recommended threshold of global
FBP-SUVR ≥1.10 in each individual (Joshi et al., 2012). The global
FBP-SUVR was calculated as the ratio of the mean FBP-SUVR of six
cortical ROIs, including frontal, temporal, precuneus, parietal, anterior
cingulate, and posterior cingulate cortices, to whole cerebellum refer-
ence region without performing PVC. The tau-positivity was defined
by using the tau cut-off threshold of composite ROIs ≥1.25 in each
individual (Mishra et al., 2017). The mean tau-SUVR in the composite
ROIs, including the entorhinal, lateral occipital, inferior temporal corti-
ces and amygdala, was divided by a mean value in the cerebellar gray
reference region to decide tau-positivity in CN at baseline (Mishra
et al., 2017). Individual FBP-SUVR and tau-SUVR images were
corrected for partial volume effects by using an extended Müller–
Gärtner (MG) method, which estimates a true radioactivity concentra-
tion in human brain GM by considering a heterogeneity of GM activity
via four-compartment model, within PetSurfer procedure (Meltzer
et al., 1996; Muller-Gartner et al., 1992; Rousset, Ma, & Evans, 1998).
A GM threshold for PVC was set at 0.1 and the point spread function
for PVC was estimated at 8 mm. Detailed methodological explanation
of MG PVC is described in a prior publication (Greve et al., 2016).
After that, individual partial volume corrected FBP-SUVR and tau-
SUVR images were coregistered to the corresponding MRI and then
registered to MNI/ICBM template by using the transformation
matrixes obtained from the previous step. All partial volume corrected
PET data were down sampled from the standard space to 6 mm iso-
voxel to avoid computational limitations of the high-dimensional data.
We used 6 mm isotropic MNI/ICBM template to define the structural
information in all PET data.
2.6 | Group averaged FBP-SUVR and tau-SUVR
To examine overall distributed patterns of both Aβ deposition and tau
deposition in CN, the group averaged FBP-SUVR map and tau-SUVR
map at baseline and 2-year FU were calculated in voxel-based MNI
space. Then, the voxel-based group averaged PET-SUVR maps were
mapped into an averaged cortical surface by mapping a value of the
middle point between inner and outer surfaces in each vertex point
via FreeSurfer recon-all procedure (FreeSurfer version 6.0.0; http://
surfer.nmr.mgh.harvard.edu/). Longitudinal changes in FBP-SUVR and
tau-SUVR between CN at 2-year FU and FU-matched baseline were
investigated using a paired t-test in each voxel, and then mapped into
an averaged cortical surface via FreeSurfer recon-all procedure
(FreeSurfer version 6.0.0; http://surfer.nmr.mgh.harvard.edu/). To
determine significant change, false discovery rate (FDR) set at
q < 0.05 was performed for multiple comparisons (Benjamini &
Hochberg, 1995).
2.7 | Graph theory-based PET correlation within
single PET modality and between PET modalities
We measured voxel-level correlations within single PET modality and
different PET modalities. We created graph theory-based correlation
matrices, which defined a node as a voxel in GM and an edge as a par-
tial correlation coefficient between a pair of voxels of PET SUVR data
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in GM across all CN. To remove confounding effects, we adjusted all
partial correlations by age, sex, as well as the PET-SUVR values of the
PET modality not included in that specific analysis (see details in the
following sections). All voxel-based partial correlations were calcu-
lated by Statistics and Machine Learning Toolbox within MATLAB.
2.7.1 | Partial PET correlation within single PET
modality
Each Aβ-to-Aβ correlation between different voxels was measured
by the partial correlation between a FBP-SUVR in a start voxel
b and a FBP-SUVR in the paired voxel d across all possible pairs of
voxels within GM in CN while controlling for age, sex, and tau-
SUVR in the paired voxel d. Similarly, each Tau-to-Tau correlation
was measured by the partial correlation between a tau-SUVR in a
start voxel b and a tau-SUVR in the paired voxel d across all possi-
ble pairs of voxels within GM in CN while controlling for age, sex,
and FBP-SUVR in the paired voxel d. We obtained 6,848-by-
6,848 matrix DwithinPET in each correlation within single PET
modality in group level. To determine significant correlation, we
corrected for multiple comparisons in each correlation matrix
DwithinPET by using a FDR set at q < 0.05 (Benjamini &
Hochberg, 1995).
2.7.2 | Partial PET correlation between different
PET modalities
Each Aβ-to-Tau correlation between different voxels was measured
by the partial correlation between a FBP-SUVR in a start voxel b and
a tau-SUVR in the paired voxel d across all possible pairs of voxels
within GM in CN while controlling for age, sex, and FBP-SUVR in the
paired voxel d (Figure 1a). Each Tau-to-Aβ correlation was measured
by the partial correlation between a tau-SUVR in a start voxel b and a
FBP-SUVR in the paired voxel d across all possible pairs of voxels
within GM in CN while controlling for age, sex, and tau-SUVR in the
paired voxel d (Figure 1a). We obtained 6,848-by-6,848 matrix
DbetweenPET in each correlation between different PET modalities in
group level. The FDR correction was performed at q as 0.05 in each
correlation matrix DbetweenPET to determine the significant correlation
(Benjamini & Hochberg, 1995).
2.7.3 | Weighted degree of the correlation matrix
We calculated the weighted degree (WD) of each voxel in each corre-
lation matrix D to identify which voxel's PET-SUVR were highly corre-
lated with PET-SUVRs of the rest of GM voxels. The WD of a voxel
b was calculated as the sum of the significant correlation coefficients
between voxel b and all possible paired voxel d, excluding a self-
connection. High WD in voxel b indicates that the PET-SUVR of the
voxel b have significantly large number of correlations to the rest of
paired-voxels in comparison with other voxels. Thus, a voxel with high
WD can be described as a hub voxel, which is strongly correlated with
the rest of the paired-voxels. The WD of all 6,848 voxels was calcu-
lated in each correlation matrix D and then resampled to the
corresponding GM voxels in the MNI template. Finally, we obtained
the WD map of Aβ-to-Aβ, Tau-to-Tau, Aβ-to-Tau, and Tau-to-Aβ
correlation matrixes in group level at baseline.
2.8 | Relationship between the information of the
graph theory-based correlation matrix and cognitive
variability
Flowchart for identifying the relationship between the averaged PET-
SUVR and cognitive variability in the PET correlation between differ-
ent PET modalities is shown in Figure 1. We examined correlation
between averaged PET-SUVRs of each paired-voxels and cognitive
scores in each PET-to-PET correlation combination. The linear associ-
ation analysis was performed to determine whether the information
of the graph theory-based PET correlations is associated with cogni-
tive variability or not, as well as to identify which PET correlation,
such as the correlation within single PET modality or the PET correla-
tion between different PET modalities, is better associated with the
cognitive variability in CN. First, we calculated the averaged PET-
SUVR between a start voxel and the paired voxel, which was defined
by a significant correlation in the PET correlation matrix D, across all
possible voxel pairs in each correlation matrix D, in each individual
level at baseline. Next, we investigated relationships between the
averaged PET-SUVR and NP scores, including MMSE, RAVALT,
ADAS-Cog, ADNI-MEM, and ADNI-EF, in each type of PET correla-
tion matrix in CN at baseline by using Pearson's partial correlation
analysis. Third, we constructed a linear plot between the averaged
PET-SUVR in each paired-voxels and each NP score to examine a lin-
ear trend between the averaged PET-SUVR in each paired-voxels and
each NP score in CN at baseline (Figure 1b).
Our correlation approach between PET-SUVRs and NP scores is
sensitive to detect direct association between the network profiles
of Aβ and tau accumulation and the cognitive scores of our samples.
Thus, they indicate whether a voxel displays an overall significant
association between network pathology and cognitive variability.
However, these correlations values do not provide information
about how initial or late are these associations along the pathologi-
cal process. To obtain this additional information, we used a
centroid-based strategy. We calculated the centroid values of
voxel-level correlations in order to determinate whether an Aβ, tau
and NP correlation was predominantly populated by values in spe-
cific areas of the dispersion graph. For instance, a low centroid value
would reflect a combination of low pathology and normal cognition
(or initial states), while a high centroid value would reflect a combi-
nation of high pathology and impaired cognition (late states)
(Figure 1b). We calculated centroid values of the cognition-related
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averaged PET-SUVRs and then made centroid maps using the CN
sample at baseline (Figure 1b,c). We only calculated the centroid if
the averaged PET-SUVRs in each paired-voxels was significantly
correlated with NP score. Next, we made spatial maps of the cen-
troid by summation of the centroid values across all possible con-
nections related to each voxel in group level to visualize the effects
of the graph theory-based single PET uptakes or multimodal PET
uptakes in cognitive variability in CN at baseline. The centroid map
was used to examine whether the centroid value of the graph
theory-based PET uptake is reliably and constantly associated with
the NP test scores in CN at both baseline and FU point for further
validation analysis.
2.8.1 | Measurement of averaged PET-SUVR
We calculated the averaged PET-SUVR between a PET-SUVR of a start
voxel and a PET-SUVR of the paired voxel, which had a significant cor-
relation in the PET correlation matrix D after performing FDR correc-
tion, in each PET correlation matrix D (Figure 1a, left side and right
bottom). The averaged PET-SUVR between a PET-SUVR of a start
voxel b (PETb) and a PET-SUVR of the paired voxel d (PETd) that linked
by ith edge (Ei) of each PET correlation matrix D in each subject k was
defined as follows:
μDk ið Þ=Avr PETb,PETdð Þ Ei of matrixD FDRcorrectedq<0:05ð Þj
F IGURE 1 Flowchart for measurement of sum of centroid values of averaged positron emission tomography (PET)-SUVR between different
modalities by using PET-to-NP correlation. (a) An averaged PET-SUVR (Avr(FBPb,taud)) was calculated by averaging between FBP-SUVR of a voxel
b (FBPb) and tau-SUVR of the paired voxel d (taud) that is significantly associated with the voxel b in FBP-to-Tau correlation matrix (DbetweenPET)
(FDR corrected q < 0.05) across all CN at baseline and 2-year FU. Then, PET-to-NP correlation matrix was calculated by Pearson's partial
correlation between the averaged PET-SUVR (Avr(FBPb,taud)) and ADAS-Cog scores while controlling for age, sex, years of education in CN at
baseline only (FDR corrected q < 0.05). (b) A centroid of the averaged PET-SUVRs was calculated by considering the scattered plots between the
averaged PET-SUVRs of each paired voxels (b,d) and ADAS-Cog scores. The centroid value was only calculated if the FBP-SUVR was significantly
correlated with tau-SUVR in the corresponding link between voxel b and voxel d from the FBP-to-Tau correlation matrix (FDR corrected
q < 0.05). (c) A sum of the centroid values in each voxel was calculated by summation of the centroid values across all possible correlations
between the voxel b and the rest of the gray matter voxels from the centroid matrix to make a spatial map of the cognition-related PET uptakes
in different PET modalities. The map of the sum of the centroid values was calculated in CN at baseline. Red color of (a) indicates high PET
uptakes. Black circle of (b) indicates each individual in CN at baseline and red cross marker of (b) indicates the centroid of the averaged PET-
SUVRs in plot distribution. Color bar of (c) indicates the sum of the centroid values in CN at baseline. ADAS-Cog, Alzheimer's Disease Assessment
Scale-Cognitive Subscale; Avr, averaged; CN, cognitively normal older adults; FBP, 18F-Florbetapir; FDR, false discovery rate; NP,
neuropsychological; SUVR, standardized uptake value ratio; tau, F18-AV-1451
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According to this equation, We obtained four types of the aver-
aged PET-SUVRs (μ), such as Avr(FBPb, FBPd), Avr(TAUb, TAUd), Avr
(FBPb, TAUd), and Avr(TAUb, FBPd), across all CN at baseline by consid-
ering each type of PET correlation matrix D. Finally, we obtained
6,848-by-6,848 matrix, which consisted of the averaged PET-SUVRs,
in each type of PET correlation matrix D in each individual. All aver-
aged PET-SUVRs were adjusted for age and sex via a general regres-
sion model by Statistics and Machine Learning Toolbox within
MATLAB.
2.8.2 | Partial correlation between the averaged
PET-SUVRs and cognitive scores
The correlations between the averaged PET-SUVRs in each paired-
voxels and NP scores, including MMSE, RAVALT, ADAS-Cog,
ADNI-MEM, and ADNI-EF, were performed by partial correlation
analysis in each type of PET correlation matrix D in CN at baseline.
We constructed four types of 6,848-by-6,848 correlation matrices
DPETNP, which consisted of the correlation coefficients between
the averaged PET-SUVRs and each NP score in group level
(Figure 1a, right upper matrix). All correlations between the
averaged PET-SUVRs and NP scores were in each correlation
matrix DPETNP, were adjusted for age, sex, and years of education
and performed FDR correction at q as 0.05 (Benjamini & Hochberg,
1995). Additionally, Bonferroni correction was performed in the
WD map (Bonferroni corrected adjusted p < .01) to confirm statisti-
cal robustness (Bonferroni, 1936).
2.8.3 | Measurement of centroid of cognition-
related PET uptakes
We constructed a linear plot between the averaged PET-SUVR in
each paired-voxels, which is defined as a link in each correlation
matrix DPETNP, and each NP across all CN at baseline to examine a lin-
ear trend between two variables at group level (Figure 1b). Then, we
calculated a centroid of the averaged PET-SUVRs from the plot
between the averaged PET-SUVRs in each paired-voxels and each NP
score by considering the distribution of the plot in group level. The
centroid was calculated by assessing cluster centroid locations in the
plot distribution between the averaged PET-SUVRs and NP scores via
k-means clustering analysis within MATLAB toolbox. The centroid
value in each link was only calculated if the averaged PET-SUVRs in
this link had significantly correlated with NP score in the correlation
matrix DPETNP (Figure 1a,b). This centroid calculation was iterated for
the number of all links of the correlation matrix DPETNP. We obtained
6,848-by-6,848 centroid matrix DCentroid in each NP score in each type
of PET correlation.
In order to visualize the effects of the graph theory-based mea-
surements, the centroid values, in cognitive variability in CN, we cal-
culated the sum of the centroid values in each voxel b by adding the
centroid values across all links connected to the voxel b in the cen-
troid matrix DCentroid, excluding self-connection (Figure 1c). The sum
of the centroid in all 6,848 voxels were calculated in each centroid
matrix DCentroid, then resampled to the corresponding GM voxels in
the MNI template. Finally, we obtained the volume-based map of the
sum of the centroid values derived from each centroid matrix DCentroid
in group level. We resampled each volume-based map of the sum of
the centroid values onto the group averaged cortical surface by map-
ping a value of middle point between inner and outer surfaces in each
vertex point via FreeSurfer recon-all procedure (FreeSurfer version
6.0.0; http://surfer.nmr.mgh.harvard.edu/) (Figure 1c).
2.9 | Longitudinal analysis
We performed a similarity approach based on the centroid map to
examine whether the PET uptakes were reliably associated with the
cognitive impairment in CN at both baseline and 2-year FU. We per-
formed spatial correlations between the centroid map and the individ-
ual averaged PET-SUVR images to determine the topological similarity
between them, across all CN at both baseline and 2-year FU. Then,
we used these spatial similarity scores from all individuals to investi-
gate whether significant associations exist between PET patterns and
cognitive scores in CN at baseline, and in an independent longitudinal
sample.
2.9.1 | Measurement of similarity score
We measured the spatial similarity between the centroid map, which
was defined by CN at baseline only, and a local corresponding voxel-
based averaged PET-SUVR map of each individual across all CN at
baseline and 2-year FU by using Pearson correlation analysis. First,
we constructed a local voxel-based averaged PET-SUVR map by
averaging a local voxel's PET-SUVR and the same voxel's PET-SUVR
across all voxels in each individual in CN at baseline and 2-year
FU. For example, if the centroid map is based on different PET
modalities, each local voxel-based averaged PET-SUVR was calcu-
lated by averaging between a local PET-SUVR and the corresponding
voxel's another PET-SUVR in each voxel in each individual level. If
the centroid map is based on the single PET modality, we just used a
single PET-SUVR map of each individual instead of the calculation of
the local voxel-based averaged PET-SUVRs. Because each voxel's
value of the centroid map was calculated by summing the centroid
values across all possible associations between the one voxel and
the rest of the GM voxels from the centroid matrix, the centroid map
was based on the local-to-distributed voxel's PET correlations.
Therefore, we used the local voxel-based averaged PET-SUVR maps,
which were based on the local-to-local PET-SUVRs, to avoid circular
dependency in the final analysis. Consequently, we obtained a simi-
larity score for each individual across all CN at baseline and
2-year FU.
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2.9.2 | Linear association between the similarity
scores and cognitive scores
To better visualize whether the high similarity scores are significantly
associated with the worsening of the cognitive test performances across
individuals, we performed linear regression analysis between the similar-
ity scores and cognitive test scores. All linear regression analyses were
performed with SurfStat MATLAB toolbox (http://www.math.mcgill.ca/
keith/surfstat). The group difference in slopes of the linear regression
lines between the FU-matched CN at baseline and CN at 2-year FU data
were tested by analysis of variance (ANOVA) within MATLAB toolbox.
3 | RESULTS
3.1 | Group demographics and clinical
characteristics
All demographic characteristics and NP tests scores are described in
Table 1. We found that most of our sample of CN displayed low levels
of amyloid and tau at baseline (threshold of global FBP-SUVR ≥ 1.10
and mean tau-SUVR in composite ROIs > 1.25). There was no signifi-
cant group difference in NP scores between 2-year FU data and FU-
matched baseline data.
3.2 | Group averaged FBP-SUVR and tau-SUVR
A high group averaged FBP-SUVR was observed in CN at baseline,
mainly in medial frontal cortex, PCC/precuneus, inferior temporal cor-
tex, and lateral occipital cortex (Figure 2a). Compared to baseline, rela-
tively higher group averaged FBP-SUVR was observed in temporal
cortex, and part of parietal cortex in CN at 2-year FU (Figure 2b). A
slightly higher group averaged tau-SUVR was observed mainly in wide
areas of the temporal cortex, MTL, medial prefrontal cortex, and PCC
in CN at baseline (Figure 2c). The group averaged tau-SUVR was more
increased in CN at 2-year FU, partly in temporal cortex (Figure 2d).
We observed significant longitudinal changes between CN at
2-year FU and FU-matched baseline in tau-SUVR, but not obviously
noted in FBP-SUVR (Supplementary Figure 3). We observed a signifi-
cantly increased FBP-SUVR in only a few spots of cortical areas
(Supplementary Figure 3a), while, a significantly increased tau-SUVR
was noted in wide areas of the temporal cortex, prefrontal cortex,
parietal cortex, and PCC in CN at 2-year FU compared with the FU-
matched baseline (Supplementary Figure 3b).
3.3 | Graph theory-based PET correlation within
single PET modality and between different PET
modalities
We observed significant PET correlation within single PET modality,
such as Aβ-to-Aβ and Tau-to-Tau correlations, as well as the PET cor-
relation between different PET modalities, such as Aβ-to-Tau and
Tau-to-Aβ correlation, in CN at baseline (FDR corrected q < 0.05,
Figure 3). Spatial distributions of WD of the PET correlation within
single PET modality, which was calculated by summation of all correla-
tion coefficients in all possible links between each voxel and the rest
of voxels, were observed across almost all cortical areas, excluding
motor cortex, in CN at baseline (Figure 3a,b). A voxel with the high
WD indicates that this voxel have the large number of connections to
the rest of voxels, that means the PET-SUVR of this voxel is strongly
correlated with the PET-SUVR of the rest of the paired voxels,
broadly. A high WD of the PET correlation was noted mainly in both
F IGURE 2 Surface-mapped
group averaged (a) FBP-SUVR and
(b) tau-SUVR in CN at all baseline
and group averaged (c) FBP-SUVR
and (d) tau-SUVR in CN at 2-year FU
after performing PVC. Red color
indicates high positron emission
tomography (PET)-SUVR. CN,
cognitively normal older adults; FBP,
18F-Florbetapir; FU, follow-up; PVC,
partial volume correction; SUVR,
standardized uptake value ratio; tau,
F18-AV-1451
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PCC/precuneus, medial frontal cortex, parietal cortex, and broad areas
of temporal cortex in Aβ-to-Aβ correlation in CN at baseline
(Figure 3a). Compared to Aβ-to-Aβ correlation, Tau-to-Tau correlation
showed relatively low WD in the temporal cortex, precuneus, and
frontal cortex in CN at baseline (Figure 3b).
A spatial distribution of WD of the PET correlations between dif-
ferent PET modalities, such as Aβ-to-Tau and Tau-to-Aβ correlations,
was shown in large areas of cortical regions in CN at baseline, but that
showed relatively lower PET correlations compared with the PET cor-
relations within single PET modality (Figure 3c,d). High WD was
observed mainly in the left lateral parietal cortex, left precuneus, left
orbitofrontal cortex, and both superior temporal cortices in Aβ-to-Tau
correlation in CN at baseline (Figure 3c). A spatial distribution of WD
of Tau-to-Aβ correlation was less spread out than the other PET cor-
relations, but showed more intensive WD pattern in both inferior
temporal cortices, both precuneus, right fusiform gyrus, and right lat-
eral parietal cortex in CN at baseline (Figure 3d).
3.4 | Relationship between the information of the
graph theory-based correlation matrix and cognitive
variability
There was a significant positive PET-to-NP correlation between aver-
aged PET-SUVRs, the mean values between FBP-SUVR of a local
voxel and tau-SUVR of the rest of voxels, and ADAS-Cog scores in
the type of Aβ-to-Tau correlation after controlling for years of educa-
tion in CN at baseline (FDR corrected q < 0.05). In contrast, no signifi-
cant correlation between the averaged PET-SUVRs and any NP scores
was found in other types of PET correlations, such as Aβ-to-Aβ, Tau-
to-Tau, and Tau-to-Aβ correlations, after performing FDR correction
in CN at baseline. In this analysis, a voxel with high WD of the PET-
to-NP correlation indicates that the averaged PET-SUVR from the dif-
ferent PET modalities between this voxel and the rest of the voxels is
strongly correlated with the NP scores, broadly. Thus, high WD
reflects the strong effects of the averaged PET-SUVR between differ-
ent PET modalities between different voxels in cognitive scores. We
found that the high averaged PET-SUVRs derived from Aβ-to-Tau
connectivity was significantly correlated with high ADAS-Cog scores
in left superior temporal cortex, left inferior cortex, left superior parie-
tal cortex, part of left PCC/precuneus, part of right superior temporal
cortex, right middle parietal cortex, right precuneus, both middle fron-
tal cortices, and both cuneus (Figure 4a). Similar topology remains sig-
nificant after performing post hoc Bonferroni correction (Figure 4b).
3.5 | Measurement of cognition-related PET
uptakes at baseline and longitudinal FU
Of note, in this section, an individual with high similarity score indi-
cates that the uptake spatial pattern of the averaged Aβ and tau PET-
SUVRs is well overlapped to the centroid map, which reflects the
F IGURE 3 Weighted degree maps of positron emission tomography (PET) correlations in CN at baseline. Cortical distributions of FBP-to-FBP
(a), Tau-to-Tau (b), FBP-to-Tau (c), and Tau-to-FBP (d) weighted degree maps in CN at baseline while adjusting for age, sex, and FBP-SUVR or
tau-SUVR when appropriate in all paired-voxels. Only multiple comparison corrected significant correlation coefficients were included in the
weighted degree maps (FDR corrected q < 0.05). Color bar indicates the weighted degree value; a high score indicates that the PET-SUVR of this
surfaced-mapped local voxel is strongly correlated with the rest of voxels, broadly. CN, cognitively normal older adults; FBP, 18F-Florbetapir;
FDR, False discovery rate; SUVR, standardized uptake value ratio; tau, F18-AV-1451
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information of the spatial patterns of cognitive impairment-related
PET uptakes. Thus, the high similarity score reflects the worsening of
the cognitive test performance. We found that increased spatial simi-
larity scores were significantly associated with increased ADAS-Cog
score in CN at baseline (t(182) = 3.22, p = .0015, Figure 5a). A similar
linear association between the similarity score and ADAS-Cog was
observed in CN at 2-year FU (t(16) = 2.41, p = .025, Figure 5b) as well
as in FU-matched baseline (t(16) = 2.36, p = .031, Figure 5b). There is
no significant slope difference between FU-matched baseline and
2-year FU groups after performing ANOVA. Although there was no
significant slope difference between FU-matched baseline and 2-year
FU, the slope was slightly higher in 2-year FU compared with the FU-
matched baseline (Figure 5b).
4 | DISCUSSION
AD is a neurodegenerative disorder in which the network-level accu-
mulation of Aβ and tau pathology seems to play a critical role in the
appearance of cognitive symptoms. Currently, we believe that close
and interdigitated spatial interactions of Aβ and tau within neural cir-
cuits might be a better indicator of early preclinical processes and
F IGURE 4 Weighted degree maps of positron emission tomography (PET)-to-NP correlations between the averaged PET-SUVRs and ADAS-
Cog scores in CN at baseline adjusted by age, sex, and years of education. (a) Only multiple comparison corrected significant correlation
coefficients were included in the weighted degree map (FDR corrected q < 0.05). (b) Bonferroni correction was also performed in the weighted
degree map (Bonferroni corrected adjusted p < .01) to confirm statistical robustness. Color bar indicates the weighted degree of PET-to-NP
correlations; a high score indicates that the averaged PET-SUVRs between this voxel and the rest of the voxels are strongly correlated with the
ADAS-Cog scores. ADAS-Cog, Alzheimer's Disease Assessment Scale-Cognitive Subscale; CN, cognitively normal older adults; FBP, 18F-
Florbetapir; FDR, False discovery rate; NP, neuropsychological scores; SUVR, standardized uptake value ratio; tau, F18-AV-1451
F IGURE 5 Linear regression associations between similarity scores and ADAS-Cog in CN at baseline and 2-year FU time point. (a) A
significant positive association between the similarity score and ADAS-Cog was noted in CN at baseline (t(182) = 3.22, p = .0015). (b) Similar
positive association was noted in both 2-year FU (t(16) = 2.41, p = .025), as well as FU-matched baseline (t(16) = 2.36, p = .031). ADAS-Cog,
Alzheimer's Disease Assessment Scale-Cognitive Subscale; CN, cognitively normal older adults; FBP, 18F-Florbetapir; FU, follow-up; SUVR,
standardized uptake value ratio; tau, F18-AV-1451
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cognitive decline of aging populations. Following this line of research,
in the present study, we used a novel graph-theory approach to inves-
tigate brain network profiles of Aβ and tau PET imaging and cognitive
scores. We found striking positive correlations between the Aβ-to-
Tau interactions and ADAS-Cog score, which is the most widely used
measure to assess multiple cognitive domains in AD (Mohs
et al., 1997a, 1997b; Rosen, Mohs, & Davis, 1984) and was developed
to measure general cognition, including verbal memory, nonverbal
memory, planning an executive function, attention and concentration,
praxis, and orientation (Mohs et al., 1997a, 1997b; Podhorna,
Krahnke, Shear, Harrison, & Alzheimer's Disease Neuroimaging, 2016;
Skinner et al., 2012). Particularly, we observed a high correlation
between Aβ-to-Tau interactions and ADAS-Cog in the temporal cor-
tex. This is consistent with the previous findings that show not only a
significant association between tau and cognitive impairment in MTL
(Sepulcre et al., 2018), but also that these cognition-related tau accu-
mulation in MTL are associated with an increased Aβ burden in older
adults (Schöll et al., 2016; Sperling et al., 2019) or mild-to-moderate
AD (Johnson et al., 2016). Other areas in the fronto-parieto-occipital
cortices displayed similar network-based ADAS-Cog associations. Pre-
vious literature has shown a strong relationship between local Aβ and
local tau in probable AD (Iaccarino et al., 2018), and a strong associa-
tion between the inferior temporal tau accumulation and distributed
Aβ accumulation in older adults (Sepulcre et al., 2016; Sperling
et al., 2019). Thus, although a significant association between both
pathology accumulations and cognitive decline was reported mainly in
MTL in previous studies (Johnson et al., 2016; Schöll et al., 2016;
Sperling et al., 2019), the cognition-related tau accumulation
(Ossenkoppele et al., 2019; Sepulcre et al., 2018) or Aβ accumulation
(Schöll et al., 2016) in regions beyond MTL, such as the parietal cortex,
frontal cortex, or occipital cortex, was also reported in several studies.
These selective associations of cognitive impairment or neurodegen-
erative changes with AD pathology accumulations depend on the AD
severity (Ossenkoppele et al., 2019) and Braak stages (Schöll
et al., 2016). Thus, we believe that high associations of Aβ-to-Tau
interactions and ADAS-Cog scores in MTL-related regions, as well as
the fronto-parieto-occipital lobes, may indicate specific states of net-
work interactions, from local Aβ toward distributed tau, that potenti-
ates neurodegenerative and cognitive changes via Aβ-triggered tau
(Duyckaerts, 2011; Ittner & Götz, 2011; Jacobs et al., 2018; Small &
Duff, 2008).
Our findings show that the cross-talking of Aβ-to-Tau better
explains the initial cognitive changes of CN compared to brain net-
work profiles derived from single PET modalities, such as Aβ-to-Aβ, or
Tau-to-Tau. The effects of Aβ pathology in cognitive decline generally
appeared in prodromal AD and dementia, rather than in cognitively
healthy older adults (Ossenkoppele et al., 2019). Therefore, the
absence of the significant PET-to-NP correlation in type of Aβ-to-Aβ
may be caused by the insufficient Aβ accumulation in CN at baseline,
which seems to be a late phenomenon. Similarly, no significant PET-
to-NP correlation in type of tau-to-tau was observed in CN at base-
line. Sperling et al. (2019) showed the association between cognitive
decline and tau accumulation in MTL in older adults; however, an
increased tau accumulation in the temporal cortex was commonly
observed in Braak stage of III or IV (Braak, Alafuzoff, Arzberger,
Kretzschmar, & Del Tredici, 2006; Braak & Braak, 1991b, 1995) and in
tau PET image (Johnson et al., 2016). Thus, a relatively weaker tau-to-
tau correlation in MTL may also explain the absence of the significant
PET-to-NP correlation in our study. Finally, we did not observe signifi-
cant PET-to-NP correlations in the type of Tau-to-Aβ. As we con-
trolled tau-SUVR effects in FBP-SUVRs of all possible paired-voxels
when we measured the correlation between the averaged PET-SUVR
and ADAS-Cog scores in types of Tau-to-Aβ correlation, one possible
explanation is that tau-independent Aβ may not sufficiently contribute
to the initial cognitive changes in CN at baseline even though tau-
controlled FBP-SUVR showed a strong association with the local tau-
SUVR in MTL.
Currently, the major concern to investigate the relationship
between Aβ and tau accumulations is the spatial inconsistencies
between the two brain pathologies. The lack of spatial correlation or
overlap between a local Aβ and the corresponding local tau accumula-
tions has been reported in imaging studies, which makes it difficult to
investigate their potential synergistic effects on cognitive decline in
aging. The benefit of conducting a graph theory-based approach is
that it provides a high-resolution strategy to relate these two
unmatched anatomies. Our proposed graph theory-based approach
measures the local-to-distributed correlations within and between Aβ
and tau PET modalities, thus solving the spatial inconsistency
between them. In this network-based study, we only observed signifi-
cant findings with ADAS-Cog scores. The absence of significance in
the correlation analysis between the averaged PET-SUVRs and other
NP scores included in the study is somewhat surprising. It is possible
that ADAS-Cog is the most sensitive to test in this work due to its
multi-domain nature. However, future studies are needed to examine
other PET-to-NP correlations by assessing multiple cognitive mea-
surements in both cognitively normal and impaired older adults
through multiple longitudinal FUs. Moreover, we used multicenter
ADNI data, which may have a potential bias in PET images caused by
multiple scanner types or visit sites. We observed consistency in the
cortical distribution of the mean tau-SUVRs and mean FBP-SUVRs
across three scanner types in CN at baseline (Supplementary
Figure 1). We performed one-way ANOVA to determine whether
there are any statistically significant differences in the means of PET-
SUVRs of GM between the three types of scanner, and we found no
significant difference in mean tau-SUVR or mean FBP-SUVR between
three types of scanners (Supplementary Figure 2). No meaningful
trends of group difference between two groups in the mean PET-
SUVRs was noted (Supplementary Figure 2). Nevertheless, future
studies should apply similar network PET-based strategies within uni-
center data to avoid potential scanner biases. Our study has an addi-
tional limitation: we mainly focused on a large CN sample at baseline,
and a relatively small longitudinal sample from ADNI-3 study dataset.
Therefore, larger number of FU individuals should be used and tested
in future studies.
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5 | CONCLUSION
We examined network interaction patterns within single PET modal-
ity, such as Aβ-to-Aβ or Tau-to-Tau correlations, and between differ-
ent PET modalities, such as Aβ-to-Tau or Tau-to-Aβ, at high-
resolution (voxel-level) in CN, using a graph theory-based analysis.
We observed that the PET uptakes derived from Aβ-to-Tau interdigi-
tations were significantly associated with ADAS-Cog in AD vulnerable
brain areas, a finding confirmed by our longitudinal investigation.
Therefore, our work suggests the preceding contribution of network
interactions between Aβ and tau deposits to explain initial cognitive
changes in CN prior to the conversion of dementia.
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